Form 4: Celularity Inc. Director Dean C. Kehler Acquires Shares and Options

Director Dean C. Kehler reports acquisition of restricted stock units and stock options in Celularity Inc.

Summary

• On December 19, 2024, Dean C. Kehler, a director of Celularity Inc., acquired 67,416 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) and stock options for 84,746 shares.
• The RSUs and options were granted under the Celularity Inc. 2021 Equity Incentive Plan.
• Following the transaction, Kehler directly owns 303,482 shares of Class A Common Stock, including the newly acquired RSUs.
• Kehler also directly owns derivative securities for 362,524 shares of Class A Common Stock.
• The RSUs and options vest on the earlier of December 19, 2024, or the next annual stockholder meeting, contingent upon continuous service with Celularity Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions. The acquisition of shares and options by a director is generally viewed positively, but it's not a major event.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs and options is contingent upon the Reporting Person's continuous service with the Issuer, indicating an incentive for continued involvement.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder confidence due to the director's increased stake in the company.

Key Dates